Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gallagher

Showing results (91-100 of 167) with videos related to

Pageof 17
Sort By:
Neuropsychiatric Disease and Treatment|March 21, 2009
Family history, early adversity and the hypothalamic-pituitary-adrenal (HPA) axis: Mediation of the vulnerability to mood disordersStuart Watson, Bruce M Owen, Peter Gallagher, et al.
Journal of Psychopharmacology (Oxford, England)|September 30, 2003
The effects of acute tryptophan depletion on neuropsychological functionJohn H Hughes, Peter Gallagher, Mary E Stewart, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 13, 2005
Effects of acute tryptophan depletion on mood and cognitive functioning in older recovered depressed subjectsRichard J Porter, Andrew J Phipps, Peter Gallagher, et al.
BMJ Open|January 24, 2018
Longitudinal impact of interprofessional education on attitudes, skills and career trajectories: a protocol for a quasi-experimental study in New ZealandBen Darlow, Melanie Brown, Peter Gallagher, et al.
Plos One|February 6, 2019
Impairments in cognitive performance in chronic fatigue syndrome are common, not related to co-morbid depression but do associate with autonomic dysfunctionLucy J Robinson, Peter Gallagher, Stuart Watson, et al.
Neuroimage. Clinical|October 13, 2017
Grey and white matter differences in Chronic Fatigue Syndrome - A voxel-based morphometry studyAndreas Finkelmeyer, Jiabao He, Laura Maclachlan, et al.
Plos One|October 21, 2017
Are current chronic fatigue syndrome criteria diagnosing different disease phenotypes?Laura Maclachlan, Stuart Watson, Peter Gallagher, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 6, 2004
Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorderAllan H Young, Peter Gallagher, Stuart Watson, et al.
Psychiatry Research|July 25, 2013
Performance monitoring and executive control of attention in euthymic bipolar disorder: employing the CPT-AX paradigmLucy J Robinson, Jill M Thompson, Peter Gallagher, et al.
Human Psychopharmacology|June 10, 2014
Cortisol awakening response and spatial working memory in man: a U-shaped relationshipAndrew S Moriarty, Andrew J Bradley, Kirstie N Anderson, et al.
Pageof 17

Showing results (91-100 of 167) with videos related to

Sort By:
Pageof 17
Neuropsychiatric Disease and Treatment|March 21, 2009
Family history, early adversity and the hypothalamic-pituitary-adrenal (HPA) axis: Mediation of the vulnerability to mood disordersStuart Watson, Bruce M Owen, Peter Gallagher, et al.
Journal of Psychopharmacology (Oxford, England)|September 30, 2003
The effects of acute tryptophan depletion on neuropsychological functionJohn H Hughes, Peter Gallagher, Mary E Stewart, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 13, 2005
Effects of acute tryptophan depletion on mood and cognitive functioning in older recovered depressed subjectsRichard J Porter, Andrew J Phipps, Peter Gallagher, et al.
BMJ Open|January 24, 2018
Longitudinal impact of interprofessional education on attitudes, skills and career trajectories: a protocol for a quasi-experimental study in New ZealandBen Darlow, Melanie Brown, Peter Gallagher, et al.
Plos One|February 6, 2019
Impairments in cognitive performance in chronic fatigue syndrome are common, not related to co-morbid depression but do associate with autonomic dysfunctionLucy J Robinson, Peter Gallagher, Stuart Watson, et al.
Neuroimage. Clinical|October 13, 2017
Grey and white matter differences in Chronic Fatigue Syndrome - A voxel-based morphometry studyAndreas Finkelmeyer, Jiabao He, Laura Maclachlan, et al.
Plos One|October 21, 2017
Are current chronic fatigue syndrome criteria diagnosing different disease phenotypes?Laura Maclachlan, Stuart Watson, Peter Gallagher, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 6, 2004
Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorderAllan H Young, Peter Gallagher, Stuart Watson, et al.
Psychiatry Research|July 25, 2013
Performance monitoring and executive control of attention in euthymic bipolar disorder: employing the CPT-AX paradigmLucy J Robinson, Jill M Thompson, Peter Gallagher, et al.
Human Psychopharmacology|June 10, 2014
Cortisol awakening response and spatial working memory in man: a U-shaped relationshipAndrew S Moriarty, Andrew J Bradley, Kirstie N Anderson, et al.
Pageof 17